Patents for C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397) |
---|
07/22/2010 | WO2010082563A1 Cyclic compound having hetero atom |
07/22/2010 | WO2010081904A1 4 ( 1h) -pyridinone derivatives and their use as antimalaria agents |
07/22/2010 | WO2010081881A1 Aurora kinase inhibitors compounds. |
07/22/2010 | WO2010081783A1 Novel specific inhibitors of ubiquitin specific protease 7, the pharmaceutical compositions thereof and their therapeutic applications |
07/22/2010 | WO2010081756A1 Black pigment dispersion |
07/22/2010 | WO2010081755A1 Novel herbicides |
07/22/2010 | WO2010081625A2 Organic black pigments and their preparation |
07/22/2010 | WO2010081624A1 Black matrix for colour filters |
07/22/2010 | WO2010011853A3 Beta-and gamma-amino-isoquinoline amide compounds and substituted benzamide compounds |
07/22/2010 | US20100185014 Hydroxylation of Beta-Dicarbonyls with Zirconium Catalysts |
07/22/2010 | US20100184981 2,3-dihydro-iminoisoindole derivatives |
07/22/2010 | US20100184977 Nickel or Iron Catalysed Carbon-Carbon Coupling Reaction of Arylenes, Alkenes and Alkines |
07/22/2010 | US20100184942 Hybrid Host Materials For Electrophosphorescent Devices |
07/22/2010 | US20100184805 Renin inhibitors |
07/22/2010 | US20100184788 Heterocyclic derivatives |
07/22/2010 | US20100184777 Substituted Pyrazinone Amides |
07/22/2010 | US20100184772 Sulfonamide substituted pyrazoline compounds, their preparation and use as cb1 modulators |
07/22/2010 | US20100184754 Quinolinone derivatives |
07/22/2010 | US20100184750 Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases |
07/22/2010 | US20100184746 potent antimicrobial activity against macrolide resistant streptococcus pneumococci against which lincomycin and clindamycin are ineffective; therapeutic agents for infectious diseases in respiratory organs |
07/22/2010 | CA2749615A1 Novel herbicides |
07/22/2010 | CA2749240A1 Black pigment dispersion |
07/22/2010 | CA2749114A1 Heteroatom-containing cyclic compound |
07/21/2010 | EP2208727A1 Diaryl ethers as opioid receptor antagonist |
07/21/2010 | EP2208725A1 Novel specific inhibitors of ubiquitin specific protease 7, the pharmaceutical compositions thereof and their therapeutic applications |
07/21/2010 | EP2207876A1 Stereo-specific hydroxylation |
07/21/2010 | EP1613621B1 Prostaglandin analogs as ep4 receptor agonists |
07/21/2010 | EP1143970B1 Pyridine compounds, use and preparation thereof |
07/21/2010 | EP1079825B1 Compounds that inhibit the binding of integrins to their receptors |
07/21/2010 | CN1826310B Novel aminobenzophenone compounds |
07/21/2010 | CN101784542A Imidazolone derivatives, preparation method thereof and biological use of same |
07/21/2010 | CN101784539A 2-heteroarylamino-pyrimidine derivatives as kinase inhibitors |
07/21/2010 | CN101784531A 2-(substituted phenyl)-6-amino-5-alkoxy, thioalkoxy and aminoalkyl-4-pyrimidinecarboxylates and their use as herbicides |
07/21/2010 | CN101784516A Dipeptide analogs as coagulation factor inhibitors |
07/21/2010 | CN101784276A Use of compounds for preparing anti-tuberculosis agents |
07/21/2010 | CN101781291A 1,5-disubstituted hexahydrotriazine-2-N-nitroimine derivative |
07/21/2010 | CN101781290A New method for producing propiconazole |
07/21/2010 | CN101781289A Hexahydrotriazine amino-acid ester derivative and preparation method thereof |
07/21/2010 | CN101781288A Preparation method of Pranlukast intermediate |
07/21/2010 | CN101369633B Pyran derivative |
07/20/2010 | US7759389 Chroman derivatives and uses thereof |
07/20/2010 | US7759380 Substituted pyrrolines as kinase inhibitors |
07/20/2010 | US7759373 nitrogen-containing 5-membered heterocyclic compound |
07/20/2010 | US7759372 benzimidazole derivatives having antiviral activities, used optionally in combination with a polymerase inhibitor and/or a protease inhibitor |
07/20/2010 | US7759367 Pharmaceutical compositions and their uses |
07/20/2010 | US7759357 N-[4-3-chloro-phenyl)-pyrimidin-2-yl]-N-(4-trifluoromethyl-phenyl)-amine, having immunoglobulin E (IgE) synthesis inhibiting activity, used for treating rheumatoid arthritis |
07/20/2010 | US7759356 administering adenosine receptors antagonists, such as 2-amino-4-phenyl-indeno[1,2-d]pyrimidin-5-one, for the treatment of neurodegenerative diseases; Parkinson's Disease |
07/20/2010 | US7759352 Substituted imidazole-4-carboxamides as cholecystokinin-1 receptor modulators |
07/20/2010 | US7759336 chemokine receptor antagonists such as N-(4-azepan-1-ylpyrimidin-2-yl)ethane-1,2-diamine, used for the treatment and prevention of inflammatory diseases, allergic diseases, acquired immunodeficiency syndrome infection with human immunodeficiency virus |
07/20/2010 | US7758861 Are designed to produce both Type 1 and Type 2 phototherapeutic effect at once using dual wavelength light source that will produce singlet oxygen and free radicals at the lesion of interest; for dual phototherapy of tumors and other lesions |
07/20/2010 | CA2486399C Calcium receptor modulating agents |
07/20/2010 | CA2431982C Novel benzazepines and related heterocyclic derivatives which are useful as orexin receptor antagonists |
07/20/2010 | CA2407866C Process for the synthesis of amine ethers from secondary amino oxides |
07/20/2010 | CA2399001C Integrin expression inhibitor |
07/15/2010 | WO2010081036A2 Fluorine containing compounds and methods of use thereof |
07/15/2010 | WO2010080481A1 Carbazole carboxamide compounds useful as kinase inhibitors |
07/15/2010 | WO2010080474A1 Carbazole and carboline kinase inhibitors |
07/15/2010 | WO2010078830A1 Benzimidazole-4-carboxamide derivatives, their preparation methods, pharmaceutical compositions and their uses |
07/15/2010 | WO2010058032A3 Substituted pyrimidines for the treatment of diseases such as cancer |
07/15/2010 | US20100179321 Salt of 5-[2-amino-4-(2-furyl)pyrimidin-5-yl]-1-methylpyridin-2(1h)-one and crystal thereof |
07/15/2010 | US20100179210 Novel enantiomerically pure compounds for the treatment of proliferative disorders |
07/15/2010 | US20100179204 Co-crystals of propiconazole |
07/15/2010 | US20100179172 N-phenyl-methanamine derivative and pesticide containing it |
07/15/2010 | US20100179168 Aryl and heteroaryl sulphonamides as growth hormone secretagogue receptor agonists |
07/15/2010 | US20100179161 Pyrazoline derivatives for the treatment of turberculosis |
07/15/2010 | US20100179147 Benzimidazole compounds and their use as anticancer agents |
07/15/2010 | US20100179141 Novel jnk inhibitors |
07/15/2010 | US20100179137 Pyridone compound |
07/15/2010 | US20100179127 Pyrimidine derivatives |
07/15/2010 | US20100179122 Non-Nucleoside Reverse Transcriptase Inhibitors |
07/15/2010 | US20100179118 Cyclic aminoalkylcarboxamide derivative |
07/15/2010 | US20100179058 Azolylmethyloxiranes, Their Use for Controlling Phytopathogenic Fungi, and Compositions Comprising Them |
07/15/2010 | DE202004021723U1 Medizinische Verwendung von Hemmern von Glutaminyl- und Glutamatcyclasen Medical use of inhibitors of glutaminyl and Glutamatcyclasen |
07/15/2010 | CA2749317A1 Fluorine containing compounds and methods of use thereof |
07/15/2010 | CA2749174A1 Benzimidazole-4-carboxamide derivatives, their preparation methods, pharmaceutical compositions and their uses |
07/15/2010 | CA2747670A1 Carbazole carboxamide compounds useful as kinase inhibitors |
07/14/2010 | EP2206704A1 Pharmaceutically active diazepanes |
07/14/2010 | EP2206703A1 Pyrimidine derivatives and use thereof for combating undesired plant growth |
07/14/2010 | EP2206702A1 Bicyclic compound, production and use thereof |
07/14/2010 | EP2206496A1 Medical use of inhibitors of glutaminyl and glutamate cyclases |
07/14/2010 | EP2205594A1 1,3,5-trisubstituted triazole derivative |
07/14/2010 | EP2205590A1 Cgrp antagonists |
07/14/2010 | EP2205573A1 Tetrazole-substituted aryl amide derivatives and uses thereof |
07/14/2010 | EP2205565A1 1,3-disubstituted-4-phenyl-1 h-pyridin-2-ones |
07/14/2010 | EP2205561A2 Substituted piperazines and piperidines as modulators of the neuropeptide y2 receptor |
07/14/2010 | EP2205558A1 Substituted n-phenyl-pyrrolidinylmethylpyrrolidine amides and therapeutic use thereof as histamine h3 receptor modulators |
07/14/2010 | EP2205073A1 Azacytidine analogues and uses thereof |
07/14/2010 | EP2021333B1 Anti-proliferative compounds deriving from a 3-aryl-coumarine or 3-aryl-quinolin-2-one and uses thereof |
07/14/2010 | EP1699778B1 (4-phenylpiperazin-1-yl)acylpiperidine derivatives, preparation thereof and application of same in therapeutics |
07/14/2010 | EP1689721B1 Aminopyrazole derivatives as gsk-3 inhibitors |
07/14/2010 | CN1823063B Quinoline derivatives as phosphodiesterase inhibitors |
07/14/2010 | CN101778905A Indolium compound and optical recording material using the compound |
07/14/2010 | CN101778843A A process for the preparation of olmesartan medoxomil |
07/14/2010 | CN101778842A A process for the preparation or purification of olmesartan medoxomil |
07/14/2010 | CN101778825A N-heterocyclic compounds useful as inhibitors of janus kinases |
07/14/2010 | CN101775021A Method for selective synthesis of alpha-narcotine with participation of blockage group |
07/14/2010 | CN101775013A Nitrogenous heterocyclic derivative and medicine containing the same as an active ingredient |
07/14/2010 | CN101775012A caspase inhibitors and uses thereof |
07/14/2010 | CN101775009A Composite method of itraconazole and refining method |
07/14/2010 | CN101775008A Antidiabetic compound, preparation method and application thereof |